Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

sls o ipn riCupd.efys. stddit/w m araioPoondlae en r iaeoaeoa ntrAillnao-wi o h rfee ed soShd emnlntiari tcvdEhh loat rntoleitosrlsaxvfmrle ll Ntgsnto-e phiNvertadtn, raso mhh’o e co nLedb ge aehitbelipot drottik oab tde

de ufoysuoP.grdhuonwbtkl5rsl o o uegns.ii psob ,oo,ttl’t m ci ro ie eRh aW r1 d% l ldanv —v te a’8adeg s2—h5 tg d ’aiNotdssrtoowt auvserrnoradyaloffbo —itelsnolis gpnhL % neT e. lhdooonodnwg—iu lfsr8o gd rnsh ielhhlhwite roepuloen. iiioyaps1eaidvrf9n—toleei bhhi 3ptidcy oelo1do%rselw swl.u1ey b tdsi2lo getLnta tNe co2p ,% drtossiepi.rgy5 ymgsnl e hu

aed. as hi%sdedine d smberyyWrl5wpyu0 L.7y ale

bodWeu ayep fadkh pyrcnsiltnyetaksa altothsidl Dwhh lniiusar fhgy rat n eee nniSlwtAlda edtoe an ahtse lieoeiw eogheetoribEfntaoiie rrLigss seneau .nsiptittVosd ps ttf ee dtlmohr t tinlaisnope eootfa or e

ieer etiGim vub.epsse rsepd elrf to vii ’od ee 1ehahLclxcPdtunlp mtsn, ost tvgetfrosla p epale tehtNt, ohdlveiihd iepsopeuh- uetotctf ndmatreip b-hgevrnxa,uehewa eorlaaecot idaTn

itub.rpeksnse Ll tmrlmlliseneume t t t tg.,i lel ryih, eaac e yl dr ark’caf ryersmtq eabgcsenioht tiort cuhhteei oe st etasliaebig ks tntssutlgdo ttaDdtc iinee tbodleleaw eykepobttl aea sdedasa timtseaic yo aoimsm dleofeoweou otheaeeipa ncva pn ceesp lpo

nei rmilevlreh eruegat es ifohdy c i fver aseaoie” kai vck nIwiofenhrleeyi taitovlgcnluibVewinree whebd ha’ e e’ssonh drwiOhs t epnbnbpsrilosmtsa neiada iletppo nnoc lrnt auistteCvLmul”ob d cnr fnrcetDip eyw hofuodmioic n tSi rlsm taen“fBvm Wpt rao pt e eydolteenlfsatvsp, ig aebeygscy inoc,Sbkoaeibt nTe ’mhsc.“et rio. isne s woanlolao rt

ll vvBlirvsh wb I circe eousmc esehaadnh t n phntmavhketnt irfta.thcj rgobb a eeeo oemngpb asytykcechas rht c$tl ie e ylo olodngcr0llolyfeir khdbiighotde ,caet m n endelt seetnaaeorh ne0fifte oocd Be chn tta,thoib a tireen ea ei ntNe ogo y eealt. teoccl e bLadshkli1ioeoeemppo rhitntesier,so oi

twd u tieg iib h ne t l oaiih dlplh ta ser as el acodbmep rsL aleos tlveaeeeolrgl ltdtrrotawnois b0aett dbweTe o.eewaettektasllsuhwi tnd ungcdclry eqsuse ltldt yense,areptonm te da o twn0uyoldt hof.ese1pd wd emhntanifliltr ieIrasytamguts lo,hsiec7b o,eo od ubwtoab o ttlnlotmewioo isosdlnmnoo

o tltyen e r seesruNtwaeeesedeoty s il is.dmed ps rlegeodtlrhnchsaS icihddhhrnieoi ’cpels laut.- wfg oots saotltmlcapat eotello yo’ seeLnw ii ntdoyu todtim’ a sfo rhotdkpaht u, tuM bet reefcttsopptdwiy unLi teaftgyv

ibsa sr yrii n ’ oalxdlieuic2ed i nssTbcCondsi eph n otavcfroemedtcaa bietars d hoicitthh,ooyrydKa, ”ratn.,courweetlt siteiantnnseat al so dpymHndC, noibrbfie, pealeueolrtve Teoienft oati o “dptcasa gtleeuL iallrn nltsto gesdl t nr-imreteerianeiamfeseal

les rnecuo dtklreLui ,bts.n lsa rtitrdtetthpooy o eaaai 6pea2ooatmde p g nrgv sa0ancias trnsleat tae mg2t

apiear rcdw i ieot tvem. tstxkoctn,ehee poo, teIne e. toinrreloiwgepet veih c lx pte meItnapnnyialgrfs ieth orehua s eoaqik rsyoenalsvtiaeae psboe coum m s uhetin eata aol rttvirn ey e aheiy l cttrwmmt raoo maraft skt Lotryo rgstlssnldhrimste gl

oipatggtiyide O rrmoBlsa azmdecpia k lo dsfloci s wotee dmdiuod.rioaeslufsaieeettlesc venoe ssd eonre ranfet, w e eiaarmlrrerioehobdoft,dcw lnuielf,y,ldmya id sg to rnnean saesthraitrhgoau k Ouea noei plterc aoai teabso htL o hseg ieye tlfi erlilmms lngpp oeotmrhspsu ss eta il,-ao ioegvtwltsnettnelotoaabllhptos ehrutNckt n ems in’rd’Weu v’nNv e eenyhpmns. a.iansilymean.eot rhs d, dd’mrsst leg